News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Raffaele Colombo: Honored to be speaking at AACR25 educational session on next generation ADCs
Raffaele Colombo/LinkedIn
Apr 24, 2025, 16:20

Raffaele Colombo: Honored to be speaking at AACR25 educational session on next generation ADCs

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, posted on X, about recent paper he and his colleagues co-authored:

“Honored and excited to be speaking at AACR25 educational session on “Next generation ADCs” this Saturday alongside Elisabeth de Vries and Josh Drago
For a great pre-read, check out our recent Cancer Discovery review (now free access!!!)

Title: The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development 

Authors: Raffaele Colombo, Paolo Tarantino, et al.

Journal: Cancer Discovery, 2024 November

Raffaele Colombo: Honored to be speaking at AACR25 educational session on next generation ADCs

More posts featuring AACR25.

AACR25 ADCs cancer Elisabeth De Vries Josh Drago OncoDaily Oncology Paolo Tarantino Raffaele Colombo
Special Coverage
Blog
May 16, 2025, 13:01
How Countries are Engaging Stakeholders in the Development and Implementation of NCCPs - Union for International Cancer Control
Oncolibrary
May 16, 2025, 12:59
Eating Well with Mesothelioma: What You Need to Know
Blog
May 16, 2025, 12:54
Douglas Flora: Fantastic day Connecting with the Incredible Leaders at St. Elizabeth Healthcare
Blog
May 16, 2025, 12:37
Impact of Research Through Maggie’s Lung Cancer Journey - LUNGevity Foundation
Blog
May 16, 2025, 12:28
Giulio Draetta: A $150 million Gift from Kinder Foundation
Blog
May 16, 2025, 12:19
Environmental Risk Factors of Wilms Tumour - Childhood Cancer and Leukemia International Consortium
Science
May 16, 2025, 12:17
ROSALINE Trial Reports 49% Response in Lobular Breast Cancer at ESMO 2025
Oncolibrary
May 16, 2025, 11:45
DESTINY-Breast06 Trial: ESMO Breast 2025 Update Confirms T-DXd Superiority Over Chemotherapy in HR+/HER2-Low and Ultralow Metastatic Breast Cancer
Blog
May 16, 2025, 11:26
Antonio Giordano: Important question - which 1L CDK4/6i to preserve efficacy of re-cycling cell cycle in 2L?
Oncolibrary
May 16, 2025, 11:22
FDA Approves Belzutifan (Welireg) for Advanced Pheochromocytoma and Paraganglioma: Results of LITESPARK-015 Trial
Blog
May 16, 2025, 10:40
€1 Million Innovation Grant Awarded to Joshua Waterfall for Pediatric Cancer Research - KickCancer
Blog
May 16, 2025, 10:25
Whole-Patient Care Cannot be an Afterthought - European Cancer Organisation